Neurodegenerative diseases are one of the most pressing challenges of our time and teasing out the cellular mechanisms underpinning these diseases is a key goal for researchers in the field. We talked to Stéphane Martinez of CISBIO to discuss how researchers can access information on neurodegenerative mechanisms and how we are beginning to recognize the contribution of the immune system to neurodegeneration.Read More
A receptor (drug target) can shift from a single subunit to a multi-structure in the presence of a ligand (drug compound) – a process known as "oligomerization". Now, using photon excitation microscopy, researchers report that they can uncover the various protein receptor oligomers formed in the absence or presence of different drug candidates that bind to them.Read More
Aided by advances in high-throughput technologies, the metabolomics research field has gained significant traction in recent years. We recently spoke with Baljit Ubhi, Ph.D., Global Business Lead, Metabolomics and Lipidomics Markets at SCIEX. In this interview, Ubhi provides her insight on the recent developments in metabolomics, addressing the increasing focus on the microbiome and how it impacts metabolic disease, and explores the future directions of research, such as "precision nutrition".Read More
Megatrends are overarching trends, ones that seed and embrace multiple market and technology developments. These trends already exist in our world today but are going to be even more important in the years to come. Here we highlight three technology megatrends that could be highly significant to our future.Read More
A recent collaboration between Onconova Therapeutics and Mission will utilize the Mission Bio TapestriⓇ Platform to conduct targeted single-cell DNA analysis for the study of Onconova's novel cancer therapy, Rigosertib. We spoke with Darrin Crisitello, CCO of Mission Bio, to learn more.
As scientists, we’re often subjected to certain stereotypes. We’re assumed to be smart and nerdy; we work long hours, wear lab coats, and obsess over data. Some or all of these traits and behaviors may ring true at a population level, but for individual scientists they don’t always stack up. The same disconnect applies to cells. We assume that the average phenotype is representative of all of the members of a population, but too often it is not...Read More
First-of-Its-Kind Lipidomics Excellence Award Acknowledges Forward-thinking in a Rapidly Growing FieldBlog
Technology Networks recently visited Dresden, Germany, for Lipotype's Lipid Excellence Award press talk, where we gained insights into the past, present and future of lipidomics research.Read More
We recently had the pleasure of speaking with David Younger, PhD., Co-founder and CEO of A-Alpha Bio, to learn more about AlphaSeq – a platform designed to measure millions of protein–protein interactions simultaneously.Read More
Predicting the reprogramming factors necessary to induce cell conversion has largely relied on trial and error, revealing the need for a more systematic approach.
To learn more about Mogrify's approach to achieving cell conversion through transdifferentiation, we interviewed Pierre-Louis Joffrin, Corporate Development Executive at Mogrify.